De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
about
Fatty acid metabolism and the basis of brown adipose tissue functionTranscriptional regulation of hepatic lipogenesisPathway-selective insulin resistance and metabolic disease: the importance of nutrient fluxThe Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond.Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in ratsQuantification of Bone Fatty Acid Metabolism and Its Regulation by Adipocyte Lipoprotein LipaseDifferential effects of Calca-derived peptides in male mice with diet-induced obesityHepatic ANGPTL3 regulates adipose tissue energy homeostasis.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsHepatic oleate regulates adipose tissue lipogenesis and fatty acid oxidation.Fructose ingestion acutely stimulates circulating FGF21 levels in humans.Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltrationEfficacy of massage therapy on pain and dysfunction in patients with neck pain: a systematic review and meta-analysis.How lipidomics provides new insight into drug discovery.De novo lipogenesis in metabolic homeostasis: More friend than foe?A Difference in Fatty Acid Composition of Isocaloric High-Fat Diets Alters Metabolic Flexibility in Male C57BL/6JOlaHsd Mice.Administration of pioglitazone alone or with alogliptin delays diabetes onset in UCD-T2DM rats.The transcription factor Cabut coordinates energy metabolism and the circadian clock in response to sugar sensingA major role of insulin in promoting obesity-associated adipose tissue inflammation.Hepatic Steatosis as a Marker of Metabolic Dysfunction.Contrasting Patterns in the Evolution of Vertebrate MLX Interacting Protein (MLXIP) and MLX Interacting Protein-Like (MLXIPL) Genes.Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes.FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin ResistanceDietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.Induction of the ChREBPβ Isoform Is Essential for Glucose-Stimulated β-Cell ProliferationAdipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolismHepatic fatty acid trafficking: multiple forks in the roadChREBP regulates fructose-induced glucose production independently of insulin signaling.Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humansChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells.Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map.Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.Genetic insights into cardiometabolic risk factorsDoes bariatric surgery improve adipose tissue function?Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20.Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.Hepatic glucose sensing and integrative pathways in the liver.Brown fat fuel utilization and thermogenesisA high-fat, high-saturated fat diet decreases insulin sensitivity without changing intra-abdominal fat in weight-stable overweight and obese adults.
P2860
Q26744147-253F1154-7C5E-443E-A274-003B35B2098AQ26778594-63B986D3-E943-44E9-A348-B3295D10F421Q26820876-AEEE4A5E-6FCD-488A-BFA0-8C6B555EB1CDQ30235555-14F99DD8-36AC-4847-8C73-88CD189FF8AFQ33765864-7ADD2789-B473-42EA-A42B-2BD34517164BQ33838946-3E84BB64-6785-4766-9A5A-27859FCF631CQ33860361-F55D37BD-12B2-4A97-B1A0-934DBB2FD0A7Q34490931-E39AA450-13DE-46E7-8C0F-8E97E9AE9B2DQ34800989-C52C5EA1-4295-42C8-8379-145C5F3D40A1Q35014249-E109E6AC-76CE-4384-AA43-0AA7F4E2124DQ35040490-F20AD700-30C4-48FF-A226-CB02D1F40CE7Q35067279-AE99F3BD-3AFC-4E2C-AF48-0A89A460BBF6Q35138738-182A6774-D8EC-48D6-ACE4-1247693B40E6Q35167171-249439F9-0AAB-49C7-A6DF-AD6301F25889Q35573584-EEB9027E-2678-48FB-9AE2-E432F8100357Q35670661-D15C4734-2CC4-4308-A7E8-4BC110D765CFQ35688028-2B565664-3844-406A-9F27-A91E1276D663Q35761144-A81280C5-C3A7-4C67-97C7-559589F44A3DQ35783848-FF7DEC30-A76D-4B5E-BBED-DD491FA5A8A1Q35809069-4031CFE9-8163-4332-A797-097EB8F82C4CQ35934280-1F3CFA7F-4046-44B7-B81F-9503AE6A90F4Q36021600-95167AF4-32D5-4B3F-9850-0FC446A701DDQ36164341-5FE71D68-F53A-4653-845C-02CF9F17F652Q36228570-D05C1A5F-3733-4701-A022-FC351CA9E328Q36311553-5D687A4D-DB1D-4E90-9354-B609E9DF3B78Q36834656-2DC1EC60-6100-4332-97E7-66E322CD8218Q37296476-53E06D51-BD35-4CDB-9B5F-CCACB9EA7155Q37395843-CD5F3494-9CB9-4406-B312-91CBB72184F0Q37554749-046DA196-25D0-4ED4-8764-0DF2FD1C33E6Q37571163-51352764-C4CD-4594-9F45-9B3B5F64B7A5Q37597058-89FB795B-6D40-4A1C-9961-7A06242D164BQ37617588-A74EF664-4A01-468A-B555-064A9D1C419CQ37644800-A0B091C1-DCC4-4CC4-BB9E-472BB8EE1505Q37654526-3D0CBDA7-5086-4745-AA2E-B534117B332BQ37669778-63DCD638-FFFB-485D-AA21-0DAE4B41C97CQ37719350-6F02CFFD-2E8A-46B7-9271-130811CAF633Q37727703-9A91AEB3-CEF4-4534-AF4B-AFB1713B5E5EQ38160330-CF95334E-FB41-483B-AA9F-50D84525CDF2Q38175686-FF82CE1E-B724-4CC4-8AAB-A9E053F7370FQ38399169-C7A499B2-EF71-4335-8BB4-224C7E7B3781
P2860
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
@en
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
@nl
type
label
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
@en
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
@nl
prefLabel
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
@en
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
@nl
P2093
P2860
P356
P1476
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
@en
P2093
Alexander Bartelt
Anna M Wolf
Christoph Buettner
Hans O Pinnschmidt
Jan Willem Greve
Joerg Heeren
Klaus Tödter
Leah Eissing
Ludger Scheja
Sander S Rensen
P2860
P2888
P356
10.1038/NCOMMS2537
P407
P577
2013-01-01T00:00:00Z